洋地黄制剂在心衰治疗中的进展

摘要/Abstract

中图分类号:

R972.

苏家春, 李勇. 洋地黄制剂在心衰治疗中的进展[J]. 中国临床药理学与治疗学, 1997, 2(3): 220-223.

1 Ferguson DW.Digltalis and neurohormonal abnormalities in heart failure and implications for the rapy.Am J Cardiol, 1992, 69:24G
2 Van Veldhuisen DJ, Man in't Veld AJ, Dunselman PHJM, et al.Double-blind, placecontrolled study of ibopamine and digo xin in patients with mild to moderate heart failure:Results of the Dutch Ibopamine Multicenter Trial (DIM T).J Am Coll Cardiol, 1993, 22:1564
3 Lloyd MA, Sandberg SM, Edwards BS.Role of renal Na⁺-K⁺-ATP ase in the regulation of sodium excretion under normal conditions and in a cute congestive heart failure.Circulation, 1992,85:1912
4 Krum H, Bigger JT, Goldsmith RL, et al.Effect of long-term digo xin The rapy on autonomic function in patients with chronic heart failure.J Am Coll Cardiol, 1995, 25:289
5 Brouwer J, Van Veldhuisen DJ, Man in't Veld AJ, et al.heart rate variability in patients with mild to moderate heart failure:effects of neurohumoral modulation by digoxin and ibopamine.J Am Coll Cardiol, 1995, 26:9 83
6 Cohen JN.Management of chronic heart failure.N Engl J Med, 1996, 335:490
7 Uretsky BF.Digoxin in the treatment of patients with chronic heart failure.its place in therapy.drugs Aging, 1995, 7:1
8 Uretsky BF, Young JB, Shahidi FE, et al.On behalf of the PROVED investigative Group.Multicenter, double blind, placebo controlled randomized withrawal trial of the efficacy and safety of digoxin in patients with mild to mode rate chronic heart failure not treated with converting enzyme inhibitors.J Am Coll Cardiol, 1993, 22:9 55
9 Packer M, Gheorghiade M, Young JB, et al.Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin-conver ting-enzyme inhibitors. N Engl J Med, 1993, 329:1
10 Fleg JH, Rothfeld B, Gottlieb SH, et al.effects of main taince digoxin on aerobic performance and exercise left vent ricular function in mild to mode rater heart failure due to coronary artery disease:a randomixxed, placebo-controlled, crossover trial.J Am Coll Cardiol, 1991, 17: 743
11 Kelly RA, Smith TW.Digoxin in heart failure:implications of recent trials.J Am Coll Cardiol, 1993, 22: Suppl A:107A
12 Gheorghiade M, Zarowitz BJ.Review of randomized trials of digoxin the rapy in patients with chronic heart failure.Am J Cardiol, 1992,69:48G
13 Van Veldhuisen DJ, Brouwer J, Man it't Veld AJ, et al.Progression of mild untreated heart failure during 6 months follow-up and clinical and neurohumoral effects of ibopamine and digoxin a s monThe rapy.Am J Cardiol, 1995, 75:7 96
14 Just H, Drexier H, Taylor SH, et al.for the CADS Study Group.Captopril versus digoxin in patients with coronary artery disease and mild heart failure.A Prospective, double-blind, placebo-controlled multicenter study.Herz, 1993,18(Suppl 1):436
15 Kleber FX, Thyroff-Frie singer U.Ibopamine versus digoxin in the treatment of mild congestive heart failure.Cardiology, 1990, 77(Suppl 5):75
16 BologesiR, Cucchini F, Javernaro A, et al.effects of acute K-strophantidin administration on left ventricular relaxation and filling phase in coronary artery disease. Am J Cardiol, 1992, 69:1 69
17 Eichhorn EJ, Alvarex LG, willard JE, et al.Digitalis improves my ocardial relaxation in patients with heart failure.(Abstr.)J Am Coll Cardiol, 1992, 19:2 54A
18 Bonaduce D, Petre tta M, Arrichiello P, et al.Effects of captopril treatment on left ventricular remode ling and function a fter anterior my ocardial infarction:comparsion with digitalis.J Am Coll Cardiol, 1992,19:858
19 Kober L, Torp-Pedersen C, Gasdsboll N, et al.Is digoxin an independent risk factor for long-term mortality after a cute my ocardial inf arction? Eur heart J, 1994, 15:382
20 Mancini DM, Benotti JR, Elkayam U, et al.and the PROM ISE Investigatiors and Coordinators.Antiarrhy thmic drug use and high serum levels of digoxin are idependent adverse prognostic factors in patients with chronic heart failure (abstract).Circulation, 1991, 84 (Suppl Ⅱ):11
21 Packer M.The development of positive inotropic agents for chronic heart failure:how have we gone astray ? J Am Coll Cardiol, 1993,22 (Suppl A):119A
22 Gheorghiade M, Hall V B, Jacobson G, et al.Effects of increasing maintainance dose of digoxin on left ventricular function and neurohormones in patients with chronic heart failure treated with diuretics and angio tensin-converting enzyme inhibitors.Circulation, 1995, 92:1 801
23 Cohn Jn, Johnson G, Ziesche S, et al.A Comparison of enalapril with hydralazine-isosrbide dinitrate in The treatment of chronic congestive heart failure.N Eng1 J Med, 1991,325:3 03
24 The SOLVD Investigators.effect of enalapril on survival in patients with reduced left ventriculare jection fractions and congestive heart failure.N Engl J Med, 1991, 325:293
25 Baker DW, Konstam MA, Bottorff M, et al. Management of heart failure.I.Pharmacologic treatment.JAMA, 1994, 272:1361

[1]	徐建飞, 林利. 高血压药物治疗与非药物治疗研究进展[J]. 中国临床药理学与治疗学, 2022, 27(4): 433-441.
[2]	张红霞, 吴勇杰, 高明堂. l-(2, 6-二甲基苯氧基)-2-(3, 4-二甲氧基苯乙氨基)丙烷盐酸盐对大鼠离体心脏缺血再灌注损伤的保护作用[J]. 中国临床药理学与治疗学, 2010, 15(2): 160-165.
[3]	朱深银, 周远大, 杜冠华. 黄嘌呤氧化还原酶抑制剂研究进展[J]. 中国临床药理学与治疗学, 2006, 11(10): 1081-1086.
[4]	薛浩, 高敏, 刘国树, 汪海. 盐酸埃他卡林对自发性高血压大鼠肾组织细胞外基质降解系统的影响[J]. 中国临床药理学与治疗学, 2006, 11(10): 1122-1128.
[5]	于爽, 余丽梅, 袁牧, 于泓, 吴芹, 石京山. 萘哌地尔衍生物BWYJ 抗前列腺增生的作用[J]. 中国临床药理学与治疗学, 2006, 11(8): 873-877.
[6]	乔海灵, 田鑫, 郭玉忠, 张莉蓉, 贾琳静, 郜娜, 谢敏. 马来酸氯苯那敏片健康人体药动学和相对生物利用度[J]. 中国临床药理学与治疗学, 2005, 10(12): 1416-1419.
[7]	何迎春, 郑青山. 复方赖诺普利片治疗中国人群原发性高血压的临床试验设计[J]. 中国临床药理学与治疗学, 2005, 10(12): 1427-1429.
[8]	汪芳, 王莉, 华潞, 胡颖, 康健, 张阴凤, 李一石. 连续口服不同剂量胺碘酮对健康受试者心率及心律的影响[J]. 中国临床药理学与治疗学, 2005, 10(7): 760-763.
[9]	王会玖, 黄燮南, 蒋青松, 吴芹, 孙安盛, 石京山. 萘哌地尔衍生物(BWYJ)对血管平滑肌细胞游离钙浓度的影响[J]. 中国临床药理学与治疗学, 2005, 10(7): 772-775.
[10]	安薇, 杨静, 张建忠, 汪俊军, 刘茂南. 平律复方抗实验性心律失常的作用及其机理研究[J]. 中国临床药理学与治疗学, 2005, 10(7): 776-780.
[11]	高敏, 王玉, 汪海. 埃他卡林等三种结构类型的钾通道开放剂对非血管平滑肌舒张作用的选择性[J]. 中国临床药理学与治疗学, 2005, 10(6): 633-636.
[12]	章慧洁, 彭晓玲, 王乾洲, 龚善初. 索他洛尔治疗心律失常的血药浓度与疗效的研究[J]. 中国临床药理学与治疗学, 2005, 10(5): 562-566.
[13]	戴长蓉, 罗来源. 小檗碱对豚鼠左心房和气管的作用[J]. 中国临床药理学与治疗学, 2005, 10(5): 567-569.
[14]	周四喜. 抗高血压药物临床应用分析[J]. 中国临床药理学与治疗学, 2005, 10(4): 466-470.
[15]	刘长丽, 曾繁典. 蝙蝠葛酚性碱抗氧化和降脂作用的实验研究[J]. 中国临床药理学与治疗学, 2005, 10(3): 343-347.

洋地黄制剂在心衰治疗中的进展

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价